Literature DB >> 2869261

Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS.

M W Vogt, D J Witt, D E Craven, R Byington, D F Crawford, R T Schooley, M S Hirsch.   

Abstract

Cervical secretions from 14 women seropositive for HTLV-III/LAV were obtained between days 7 and 21 of the menstrual cycle and cultured for virus. HTLV-III/LAV was isolated from cervical secretions in 4 of 14 women, as well as from blood of 7 of 13 women tested. Female genital secretions may therefore be a source for sexual transmission of the virus to men.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Americas; Biology; Cervical Mucus; Cervix; Developed Countries; Developing Countries; Diseases; Genitalia; Genitalia, Female; Hiv Infections; North America; Northern America; Physiology; United States; Urogenital System; Uterus; Viral Diseases

Mesh：

Year:  1986        PMID： 2869261     DOI： 10.1016/s0140-6736(86)90884-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  38 in total

1.  The innate immune system: gatekeeper to the female reproductive tract.

Authors:  Charles R Wira; John V Fahey
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

2.  Presence of human immunodeficiency virus nucleic acids in wastewater and their detection by polymerase chain reaction.

Authors:  S A Ansari; S R Farrah; G R Chaudhry
Journal:  Appl Environ Microbiol       Date:  1992-12       Impact factor: 4.792

Review 3.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

4.  Seroprevalence, risk factors and attitude to HIV-1 in a representative sample of lesbians in Turin.

Authors:  R Raiteri; R Fora; P Gioannini; R Russo; A Lucchini; M G Terzi; D Giacobbi; A Sinicco
Journal:  Genitourin Med       Date:  1994-06

5.  Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120.

Authors:  Y Furuta; K Eriksson; B Svennerholm; P Fredman; P Horal; S Jeansson; A Vahlne; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  Crack, crack house sex, and HIV risk.

Authors:  J A Inciardi
Journal:  Arch Sex Behav       Date:  1995-06

7.  Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Authors:  Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

8.  Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia.

Authors:  L A Hussain; T Lehner
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

9.  Infrequent detection of HIV-1 components in tears compared to blood of HIV-1-infected persons.

Authors:  A J Mueller; V Klauss; L Gürtler; S Geier
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

Review 10.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.